Terms: = Skin cancer AND TOP2A, TOP2, TP2A
18 results:
1. The high expression of top2a and MELK induces the occurrence of psoriasis.
Zhu X; Zhang E; Qin L
Aging (Albany NY); 2024 Feb; 16(4):3185-3199. PubMed ID: 38382096
[TBL] [Abstract] [Full Text] [Related]
2. Expression of microRNAs and their target genes in melanomas originating from gynecologic sites.
DiVincenzo MJ; Angell CD; Suarez-Kelly LP; Ren C; Barricklow Z; Moufawad M; Fadda P; Yu L; Backes FJ; Ring K; Mills A; Slingluff C; Chung C; Gru AA; Carson WE
PLoS One; 2023; 18(6):e0285804. PubMed ID: 37384650
[TBL] [Abstract] [Full Text] [Related]
3. Exploring Potential Biomarkers, Ferroptosis Mechanisms, and Therapeutic Targets Associated with Cutaneous Squamous Cell Carcinoma via Integrated Transcriptomic Analysis.
Su W; Huang B; Zhang Q; Han W; An L; Guan Y; Ji J; Yu D
J Healthc Eng; 2022; 2022():3524022. PubMed ID: 36247089
[TBL] [Abstract] [Full Text] [Related]
4. Comparison of the biomarkers for targeted therapies in primary extra-mammary and mammary Paget's disease.
Gatalica Z; Vranic S; Krušlin B; Poorman K; Stafford P; Kacerovska D; Senarathne W; Florento E; Contreras E; Leary A; Choi A; In GK
Cancer Med; 2020 Feb; 9(4):1441-1450. PubMed ID: 31899853
[TBL] [Abstract] [Full Text] [Related]
5. Identification of Key Genes and Pathways in Cervical cancer by Bioinformatics Analysis.
Wu X; Peng L; Zhang Y; Chen S; Lei Q; Li G; Zhang C
Int J Med Sci; 2019; 16(6):800-812. PubMed ID: 31337953
[TBL] [Abstract] [Full Text] [Related]
6. Profiles of brain metastases: Prioritization of therapeutic targets.
Ferguson SD; Zheng S; Xiu J; Zhou S; Khasraw M; Brastianos PK; Kesari S; Hu J; Rudnick J; Salacz ME; Piccioni D; Huang S; Davies MA; Glitza IC; Heymach JV; Zhang J; Ibrahim NK; DeGroot JF; McCarty J; O'Brien BJ; Sawaya R; Verhaak RGW; Reddy SK; Priebe W; Gatalica Z; Spetzler D; Heimberger AB
Int J Cancer; 2018 Dec; 143(11):3019-3026. PubMed ID: 29923182
[TBL] [Abstract] [Full Text] [Related]
7. Vulvar and vaginal melanoma: A unique subclass of mucosal melanoma based on a comprehensive molecular analysis of 51 cases compared with 2253 cases of nongynecologic melanoma.
Hou JY; Baptiste C; Hombalegowda RB; Tergas AI; Feldman R; Jones NL; Chatterjee-Paer S; Bus-Kwolfski A; Wright JD; Burke WM
Cancer; 2017 Apr; 123(8):1333-1344. PubMed ID: 28026870
[TBL] [Abstract] [Full Text] [Related]
8. Diagnostic and Prognostic Value of ProEx C and GLUT1 in Melanocytic Lesions.
Yan S; Coffing BN; Li Z; Xie H; Brennick JB; Beg HA; Froehlich HM; Wells WA
Anticancer Res; 2016 Jun; 36(6):2871-80. PubMed ID: 27272799
[TBL] [Abstract] [Full Text] [Related]
9. Immunohistochemical and molecular profiling of histologically defined apocrine carcinomas of the breast.
Vranic S; Marchiò C; Castellano I; Botta C; Scalzo MS; Bender RP; Payan-Gomez C; di Cantogno LV; Gugliotta P; Tondat F; di Celle PF; Mariani S; Gatalica Z; Sapino A
Hum Pathol; 2015 Sep; 46(9):1350-9. PubMed ID: 26208846
[TBL] [Abstract] [Full Text] [Related]
10. Influence of cyclosporin A on expression pattern of genes associated with dna repair in human dermal fibroblasts.
Hibner G; Zajdel A; Wilczok A
Acta Pol Pharm; 2014; 71(6):966-71. PubMed ID: 25745769
[TBL] [Abstract] [Full Text] [Related]
11. DNA repair and replication proteins as prognostic markers in melanoma.
Song L; Robson T; Doig T; Brenn T; Mathers M; Brown ER; Doherty V; Bartlett JM; Anderson N; Melton DW
Histopathology; 2013 Jan; 62(2):343-50. PubMed ID: 23020778
[TBL] [Abstract] [Full Text] [Related]
12. Topoisomerase II-mediated DNA cleavage and mutagenesis activated by nitric oxide underlie the inflammation-associated tumorigenesis.
Yang YC; Chou HY; Shen TL; Chang WJ; Tai PH; Li TK
Antioxid Redox Signal; 2013 Apr; 18(10):1129-40. PubMed ID: 22998676
[TBL] [Abstract] [Full Text] [Related]
13. Large-scale integration of microarray data reveals genes and pathways common to multiple cancer types.
Dawany NB; Dampier WN; Tozeren A
Int J Cancer; 2011 Jun; 128(12):2881-91. PubMed ID: 21165954
[TBL] [Abstract] [Full Text] [Related]
14. Patterns of expression of DNA repair genes and relapse from melanoma.
Jewell R; Conway C; Mitra A; Randerson-Moor J; Lobo S; Nsengimana J; Harland M; Marples M; Edward S; Cook M; Powell B; Boon A; de Kort F; Parker KA; Cree IA; Barrett JH; Knowles MA; Bishop DT; Newton-Bishop J
Clin Cancer Res; 2010 Nov; 16(21):5211-21. PubMed ID: 20705614
[TBL] [Abstract] [Full Text] [Related]
15. Bisindenoisoquinoline bis-1,3-{(5,6-dihydro-5,11-diketo-11H-indeno[1,2-c]isoquinoline)-6-propylamino}propane bis(trifluoroacetate) (NSC 727357), a DNA intercalator and topoisomerase inhibitor with antitumor activity.
Antony S; Agama KK; Miao ZH; Hollingshead M; Holbeck SL; Wright MH; Varticovski L; Nagarajan M; Morrell A; Cushman M; Pommier Y
Mol Pharmacol; 2006 Sep; 70(3):1109-20. PubMed ID: 16798938
[TBL] [Abstract] [Full Text] [Related]
16. Molecular classification of melanoma using real-time quantitative reverse transcriptase-polymerase chain reaction.
Lewis TB; Robison JE; Bastien R; Milash B; Boucher K; Samlowski WE; Leachman SA; Dirk Noyes R; Wittwer CT; Perreard L; Bernard PS
Cancer; 2005 Oct; 104(8):1678-86. PubMed ID: 16116595
[TBL] [Abstract] [Full Text] [Related]
17. Molecular profiling of malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1, based on large-scale real-time RT-PCR.
Lévy P; Vidaud D; Leroy K; Laurendeau I; Wechsler J; Bolasco G; Parfait B; Wolkenstein P; Vidaud M; Bièche I
Mol Cancer; 2004 Jul; 3():20. PubMed ID: 15255999
[TBL] [Abstract] [Full Text] [Related]
18. Comparative genomic hybridization analysis of primary cutaneous B-cell lymphomas: identification of common genomic alterations in disease pathogenesis.
Mao X; Lillington D; Child F; Russell-Jones R; Young B; Whittaker S
Genes Chromosomes Cancer; 2002 Oct; 35(2):144-55. PubMed ID: 12203778
[TBL] [Abstract] [Full Text] [Related]
